Abstract:Erythropoietin-producing hepatocellular carcinoma cell surface type-A receptor 3 (EPHA3) has been found to promote the proliferation and survival of prostate cancer (PCa) cell lines and prostate tumor development in nude mice. However, the regulation of EPHA3 in PCa remains largely unknown. This study is aimed to investigate the association between EPHA3 expression and androgen receptor (AR) signaling and the potential mechanism. We determined mRNA and protein levels of EPHA3 and AR signaling-related genes in the PCa cell line 22Rv1 by reverse transcription-polymerase chain reaction (RT-PCR) and western blotting, respectively. The EPHA3 mRNA and protein levels were both found to be elevated by dihydrotestosterone (DHT) hormone in a dose- and time-dependent manner, as AR and prostate-specific antigen (PSA) expression were increased. Similarly, EPHA3 protein levels were also increased in the PCa cell line LNCaP stimulated with DHT or mibolerone (Mib). Overexpression of pEGFP-AR in 22Rv1 cells significantly increased the EphA3 level, while AR knockdown with small interfering RNA (siRNA) for AR (siAR) markedly decreased the expression of EPHA3. The key EPHA3 promoter region associated with AR regulation was evaluated by co-transfection of various pGL3-basic-luciferase reporter plasmids, containing EPHA3 core promoter fragments differing in length, with the AR plasmid or siAR into 22Rv1 cells. AR overexpression in 22Rvl cells raised the EphA3 promoter transcription activity of pGL3-EPHA3-Luc (EPHA3-Luc)-789, and vice versa. Similarly, luciferase activity of EPHA3-Luc-317 was also clearly affected. However, truncated EPHA3-Luc-237 without the transcription factor specific protein 1 (SP1) binding sites or EPHA3-Luc-789SP1 with modified SP1 binding sites clearly decreased EPHA3 promoter activity regardless of whether AR was overexpressed or blocked. Treatment of 22Rv1 cells with 10 and 100 nM of the SP1 inhibitor mithramycin A for 24 and 48 h significantly reduced EPHA3 mRNA and protein levels. Additionally, selective inhibition of SP1 with siRNA SP1 (siSP1) at various concentration from 25 to 75 nM, reduced the EPHA3 protein level in PCa LNCaP cells, accordingly. Co-immunoprecipitation (co-IP) and chromatin IP (ChIP) assays were performed to determine whether AR forms a transcription factor complex with Sp1 that binds the EPHA3 core promoter region to sense androgen induction. The result suggests that the interaction of AR and SP1 contributes to regulate EPHA3 expression, and the SP1 binding sites (-295 similar to-261) in the EPHA3 core promoter region is crucial to the regulation of EPHA3 expression in response to androgen hormone stimuli.

AR Imposes Different Effects on ZFHX3 Transcription Depending on Androgen Status in Prostate Cancer Cells

Orphan Nuclear Receptor TLX Contributes to Androgen Insensitivity in Castration-Resistant Prostate Cancer Via Its Repression of Androgen Receptor Transcription.

Increased Prlz-Mediated Androgen Receptor Transactivation Promotes Prostate Cancer Growth At Castration-Resistant Stage

ZFHX3 is indispensable for ERβ to inhibit cell proliferation via MYC downregulation in prostate cancer cells

AR-regulated ZIC5 Contributes to the Aggressiveness of Prostate Cancer

Histone Acetyltransferase 1 Upregulates Androgen Receptor Expression to Modulate CRPC Cell Resistance to Enzalutamide.

Androgen Receptor Induces EPHA3 Expression by Interacting with Transcription Factor SP1

HMGB1 Promotes the Development of Castration‑resistant Prostate Cancer by Regulating Androgen Receptor Activation

Restoration of FKBP51 Protein Promotes the Progression of Castration Resistant Prostate Cancer

Regulatory Mechanism of Androgen Receptor on NCAPD3 Gene Expression in Prostate Cancer.

HOXB3 Drives WNT-activation Associated Progression in Castration-Resistant Prostate Cancer

Transcriptional Repression By Androgen Receptor: Roles In Castration-Resistant Prostate Cancer

Androgen Receptor Signaling and Spatial Chromatin Organization in Castration-Resistant Prostate Cancer

Knockdown of Zinc Finger Protein X-linked Inhibits Prostate Cancer Cell Proliferation and Induces Apoptosis by Activating Caspase-3 and Caspase-9

UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

Androgen Receptor Level Controlled by a Suppressor Complex Lost in an Androgen-Independent Prostate Cancer Cell Line.

KLF5 is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells

CYP19A1 is Downregulated by BRD4 and Suppresses Castration-Resistant Prostate Cancer Cell Invasion and Proliferation by Decreasing AR Expression.

Estrogen induces androgen‐repressed SOX4 expression to promote progression of prostate cancer cells

Androgen Receptor Functioned As a Suppressor in the Prostate Cancer Cell Line PC3 in Vitro and in Vivo.